Evaluation of choline acetyltransferase gene polymorphism (2384 G/A) in Alzheimer's disease and mild cognitive impairment

Dement Geriatr Cogn Disord. 2008;26(1):9-14. doi: 10.1159/000140612. Epub 2008 Jun 19.

Abstract

Background/aims: It has been hypothesized that choline acetyltransferase (ChAT) activity might be associated with cognitive impairment in Alzheimer's disease (AD). A functional single nucleotide polymorphism (2384 G/A) of ChAT was proposed to be associated with AD risk and age of onset. The aim of this study was to evaluate this polymorphism in a cohort of Chinese AD patients and patients with mild cognitive impairment (MCI).

Methods: We conducted a case-control study in 273 cases of sporadic AD, 97 MCI patients and 271 nondemented controls from the Chinese Han population.

Results: In AD, ChAT 2384 A carriers had a significantly earlier age of onset and worse individual cognitive function in Fuld Object-Memory Evaluation; in MCI, the carriers of both 2384 A and ApoE epsilon4 had a significantly earlier age of onset.

Conclusion: ChAT 2384 A allele is a risk factor for AD and MCI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / ethnology*
  • Alzheimer Disease / genetics*
  • Asian People / genetics
  • Asian People / statistics & numerical data
  • Choline O-Acetyltransferase / genetics*
  • Cognition Disorders / ethnology*
  • Cognition Disorders / genetics*
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease / ethnology
  • Genotype
  • Humans
  • Male
  • Neuropsychological Tests
  • Polymorphism, Single Nucleotide
  • Risk Factors
  • Severity of Illness Index

Substances

  • Choline O-Acetyltransferase